BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30512122)

  • 21. Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.
    Lavonas EJ; Schaeffer TH; Kokko J; Mlynarchek SL; Bogdan GM
    BMC Emerg Med; 2009 Jun; 9():13. PubMed ID: 19545426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri).
    Bush SP; Green SM; Moynihan JA; Hayes WK; Cardwell MD
    Ann Emerg Med; 2002 Dec; 40(6):619-24. PubMed ID: 12447339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States.
    Dart RC; Seifert SA; Boyer LV; Clark RF; Hall E; McKinney P; McNally J; Kitchens CS; Curry SC; Bogdan GM; Ward SB; Porter RS
    Arch Intern Med; 2001 Sep; 161(16):2030-6. PubMed ID: 11525706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial Experience with F(ab')2 Antivenom Compared with Fab Antivenom for Rattlesnake Envenomations Reported to a single poison center during 2019.
    Wilson BZ; Bahadir A; Andrews M; Karpen J; Winkler G; Smelski G; Dudley S; Walter FG; Shirazi FM
    Toxicon; 2022 Apr; 209():10-17. PubMed ID: 35085602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.
    Lavonas EJ; Kokko J; Schaeffer TH; Mlynarchek SL; Bogdan GM; Dart RC
    Ann Emerg Med; 2011 Feb; 57(2):128-137.e3. PubMed ID: 20952098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation.
    Ruha AM; Curry SC; Beuhler M; Katz K; Brooks DE; Graeme KA; Wallace K; Gerkin R; Lovecchio F; Wax P; Selden B
    Ann Emerg Med; 2002 Jun; 39(6):609-15. PubMed ID: 12023703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of delayed use of crotalidae polyvalent immune Fab (ovine) antivenom.
    Bebarta V; Dart RC
    J Toxicol Clin Toxicol; 2004; 42(3):321-4. PubMed ID: 15362603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Tissue Loss After Agkistrodon Snakebite: Appropriate Use of Crotalidae-Fab Antivenin.
    Larson KW; Schaefer KR; Austin C; Norton R; Finley PJ
    J Trauma Nurs; 2016; 23(3):169-72. PubMed ID: 27163225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
    Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reply: severe anaphylactic reaction following crotalidae polyvalent immune fab (ovine) administration for copperhead snakebite.
    Bush SP; Lepak MR
    Ann Pharmacother; 2015 Apr; 49(4):497-8. PubMed ID: 25762656
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment: severe anaphylactic reaction following crotalidae polyvalent immune fab (ovine) administration for copperhead snakebite.
    Mullins ME; Liss DB; Schwarz ES
    Ann Pharmacother; 2015 Apr; 49(4):496. PubMed ID: 25762655
    [No Abstract]   [Full Text] [Related]  

  • 32. FabAV antivenin use after copperhead snakebite: clinically indicated or knee-jerk reaction?
    Gale SC; Peters JA; Allen L; Creath R; Dombrovskiy VY
    J Venom Anim Toxins Incl Trop Dis; 2016; 22():2. PubMed ID: 26766940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom.
    Clark RF; McKinney PE; Chase PB; Walter FG
    Ann Emerg Med; 2002 Jun; 39(6):671-6. PubMed ID: 12023714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with difficulty achieving initial control with crotalidae polyvalent immune fab antivenom in snakebite patients.
    Yin S; Kokko J; Lavonas E; Mlynarchek S; Bogdan G; Schaeffer T
    Acad Emerg Med; 2011 Jan; 18(1):46-52. PubMed ID: 21166732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Snakebite! Crotalinae Envenomation of a Man in Rhode Island.
    Zhang XC; Kearney A; Gibbs FJ; Hack JB
    R I Med J (2013); 2016 Jan; 99(1):25-7. PubMed ID: 26726858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
    Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
    Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Copperhead snakebite treated with crotalidae polyvalent immune fab (ovine) antivenom in third trimester pregnancy.
    Kravitz J; Gerardo CJ
    Clin Toxicol (Phila); 2006; 44(3):353-4. PubMed ID: 16749561
    [No Abstract]   [Full Text] [Related]  

  • 38. Marked Hypofibrinogenemia and Gastrointestinal Bleeding After Copperhead (Agkistrodon contortrix) Envenomation.
    Kopec KT; Yen M; Bitner M; Evans CS; Gerardo CJ
    Wilderness Environ Med; 2015 Dec; 26(4):488-90. PubMed ID: 26432425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Acute Hypersensitivity Reactions in Pediatric Patients Receiving Crotalidae Polyvalent Immune Fab.
    Corbett B; Otter J; Masom CP; Clark RF
    J Med Toxicol; 2021 Jan; 17(1):48-50. PubMed ID: 32710249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Response to "The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery from Copperhead Snake Envenomation".
    Chiang W; Harding SA; Tassin SA; Nguyen V; Su M
    Ann Emerg Med; 2017 Dec; 70(6):930-931. PubMed ID: 29157700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.